Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 15 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 22 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2018 Filed Jan 3, 2019 23:07 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Tax withholdingCommon Stock | 151 | $24.46 | $3,693.46 |
DisclosureSEC source: 0000898432-19-000017 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,959 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 23:07 UTC |
JOHNSON BRENTExec. VP. Sales & Marketing
|
Exercise / conversionCommon Stock | 617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000017 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,110 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 23:04 UTC |
Scott Christopher K.CFO & Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,715 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-000015 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,716 Underlying: Common Stock · 2,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2019 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 23:04 UTC |
Scott Christopher K.CFO & Secretary
|
Tax withholdingCommon Stock | 662 | $24.46 | $16,192.52 |
DisclosureSEC source: 0000898432-19-000015 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,971 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 23:04 UTC |
Scott Christopher K.CFO & Secretary
|
Exercise / conversionCommon Stock | 2,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-000015 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:18 UTC |
Casey Francis X.VP of Reg and Qual Assur
|
Exercise / conversionRestricted Stock Units · Derivative | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001510 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850 Underlying: Common Stock · 425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:18 UTC |
Casey Francis X.VP of Reg and Qual Assur
|
Tax withholdingCommon Stock | 104 | $27.02 | $2,810.08 |
DisclosureSEC source: 0000898432-18-001510 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,712 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:18 UTC |
Casey Francis X.VP of Reg and Qual Assur
|
Exercise / conversionCommon Stock | 425 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001510 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:32 UTC |
Waldman Louis S.Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001516 · form4.xml · derivative · entry 4 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:32 UTC |
Waldman Louis S.Controller
|
Tax withholdingCommon Stock | 183 | $27.02 | $4,944.66 |
DisclosureSEC source: 0000898432-18-001516 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 F2 · price: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:32 UTC |
Waldman Louis S.Controller
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001516 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:37 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001518 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:37 UTC |
Nardi Steven M.VP MANUFACTURING
|
Tax withholdingCommon Stock | 183 | $27.02 | $4,944.66 |
DisclosureSEC source: 0000898432-18-001518 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:37 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001518 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:23 UTC |
Kennedy JonathanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,348 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001513 · form4.xml · derivative · entry 2 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 17:23 UTC |
Kennedy JonathanDirector
|
Exercise / conversionCommon Stock | 4,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001513 · form4.xml · nonDerivative · entry 1 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:39 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,348 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001519 · form4.xml · derivative · entry 2 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:39 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionCommon Stock | 4,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001519 · form4.xml · nonDerivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:35 UTC |
Scott Christopher K.Chief Financial Officer & Secr
|
Exercise / conversionRestricted Stock Units · Derivative | 3,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001517 · form4.xml · derivative · entry 3 Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,834 Underlying: Common Stock · 3,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:35 UTC |
Scott Christopher K.Chief Financial Officer & Secr
|
Tax withholdingCommon Stock | 833 | $27.02 | $22,507.66 |
DisclosureSEC source: 0000898432-18-001517 · form4.xml · nonDerivative · entry 2 Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,918 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:35 UTC |
Scott Christopher K.Chief Financial Officer & Secr
|
Exercise / conversionCommon Stock | 3,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001517 · form4.xml · nonDerivative · entry 1 Scott Christopher K. · CIK 0001613803 · Chief Financial Officer & Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:20 UTC |
JOHNSON BRENTEXEX. VP, SALES & MARKETING
|
Exercise / conversionRestricted Stock Units · Derivative | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001511 · form4.xml · derivative · entry 3 JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:20 UTC |
JOHNSON BRENTEXEX. VP, SALES & MARKETING
|
Tax withholdingCommon Stock | 183 | $27.02 | $4,944.66 |
DisclosureSEC source: 0000898432-18-001511 · form4.xml · nonDerivative · entry 2 JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,493 Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:20 UTC |
JOHNSON BRENTEXEX. VP, SALES & MARKETING
|
Exercise / conversionCommon Stock | 750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001511 · form4.xml · nonDerivative · entry 1 JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:17 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 4,348 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001509 · form4.xml · derivative · entry 2 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 14, 2016, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 14, 2017. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 22:17 UTC |
ALLEN MONTY KDirector
|
Exercise / conversionCommon Stock | 4,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001509 · form4.xml · nonDerivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:35 UTC |
McCreery John KChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 4,330 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001458 · form4.xml · derivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,330 Underlying: Common Stock · 4,330 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:25 UTC |
Waldman Louis S.Controller
|
GrantRestricted Stock Units · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001454 · form4.xml · derivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:41 UTC |
Casey Francis X.VP of Reg and Qual Assur
|
GrantRestricted Stock Units · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001461 · form4.xml · derivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:33 UTC |
Nardi Steven M.VP MANUFACTURING
|
GrantRestricted Stock Units · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001457 · form4.xml · derivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2018 Filed Dec 11, 2018 19:37 UTC |
Kennedy JonathanDirector
|
GrantRestricted Stock Units · Derivative | 3,937 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001459 · form4.xml · derivative · entry 1 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,937 Underlying: Common Stock · 3,937 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:39 UTC |
JOHNSON BRENTEXEX. VP, SALES & MARKETING
|
GrantRestricted Stock Units · Derivative | 1,574 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001460 · form4.xml · derivative · entry 1 JOHNSON BRENT · CIK 0001254747 · EXEX. VP, SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,574 Underlying: Common Stock · 1,574 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:26 UTC |
ALLEN MONTY KDirector
|
GrantRestricted Stock Units · Derivative | 3,937 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001455 · form4.xml · derivative · entry 1 ALLEN MONTY K · CIK 0001253352 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,937 Underlying: Common Stock · 3,937 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:23 UTC |
VUOTO ANTHONYDirector
|
GrantRestricted Stock Units · Derivative | 3,937 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001453 · form4.xml · derivative · entry 1 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,937 Underlying: Common Stock · 3,937 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 07, 2018 Filed Dec 12, 2018 00:31 UTC |
Scott Christopher K.CFO & Secretary
|
GrantRestricted Stock Units · Derivative | 6,299 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001456 · form4.xml · derivative · entry 1 Scott Christopher K. · CIK 0001613803 · CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,299 Underlying: Common Stock · 6,299 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. F2 · derivative.exercise_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 7, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:04 UTC |
McCreery John KChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001415 · form4.xml · derivative · entry 3 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:04 UTC |
McCreery John KChief Operating Officer
|
Tax withholdingCommon Stock | 180 | $26.78 | $4,820.40 |
DisclosureSEC source: 0000898432-18-001415 · form4.xml · nonDerivative · entry 2 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,183 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:04 UTC |
McCreery John KChief Operating Officer
|
Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001415 · form4.xml · nonDerivative · entry 1 McCreery John K · CIK 0001703458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 17:56 UTC |
Casey Francis X.VP of Reg and Qual Assur
|
Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001412 · form4.xml · derivative · entry 3 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 17:56 UTC |
Casey Francis X.VP of Reg and Qual Assur
|
Tax withholdingCommon Stock | 178 | $26.78 | $4,766.84 |
DisclosureSEC source: 0000898432-18-001412 · form4.xml · nonDerivative · entry 2 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,391 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 17:56 UTC |
Casey Francis X.VP of Reg and Qual Assur
|
Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001412 · form4.xml · nonDerivative · entry 1 Casey Francis X. · CIK 0001613661 · VP of Reg and Qual Assur 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:18 UTC |
Waldman Louis S.Controller
|
Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001419 · form4.xml · derivative · entry 4 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:18 UTC |
Waldman Louis S.Controller
|
Tax withholdingCommon Stock | 180 | $26.78 | $4,820.40 |
DisclosureSEC source: 0000898432-18-001419 · form4.xml · nonDerivative · entry 2 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:18 UTC |
Waldman Louis S.Controller
|
Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001419 · form4.xml · nonDerivative · entry 1 Waldman Louis S. · CIK 0001613666 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:08 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionRestricted Stock Units · Derivative | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001416 · form4.xml · derivative · entry 3 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:08 UTC |
Nardi Steven M.VP MANUFACTURING
|
Tax withholdingCommon Stock | 180 | $26.78 | $4,820.40 |
DisclosureSEC source: 0000898432-18-001416 · form4.xml · nonDerivative · entry 2 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558 Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:08 UTC |
Nardi Steven M.VP MANUFACTURING
|
Exercise / conversionCommon Stock | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001416 · form4.xml · nonDerivative · entry 1 Nardi Steven M. · CIK 0001613663 · VP MANUFACTURING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:01 UTC |
Kennedy JonathanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001414 · form4.xml · derivative · entry 2 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,690 Underlying: Common Stock · 3,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 18:01 UTC |
Kennedy JonathanDirector
|
Exercise / conversionCommon Stock | 3,690 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-18-001414 · form4.xml · nonDerivative · entry 1 Kennedy Jonathan · CIK 0001451629 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 23:14 UTC |
VUOTO ANTHONYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,690 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-18-001418 · form4.xml · derivative · entry 2 VUOTO ANTHONY · CIK 0001222060 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,690 Underlying: Common Stock · 3,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. F2 · derivative.expiration_date: On December 4, 2017, The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.